Education
About Us
Working with TipRanks
Follow Us
Alan Dunton Insider Profile
74 Followers
Alan Dunton, Director at Palatin Technologies, holds 14.08K shares in Palatin Technologies (Ticker: PTN), holds 40.25K shares in Cormedix (Ticker: CRMD), holds 25.62K shares in Oragenics (Ticker: OGEN).
Profitable Transactions
9 out of 11 Profitable Transactions
Average Return
+66.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Alan Dunton holds in companies
Most Profitable Insider Trade
The most profitable trade made by Alan Dunton
Alan Dunton's Trading History
Palatin Technologies
Dec 11, 2025
Director
Uninformative Buy
―
$205.72K
Cormedix
Sep 16, 2025
Director
Uninformative Buy
35.50K
$504.33K
Gyre Therapeutics
Dec 12, 2014
Director
Uninformative Buy
―
$72.60K
Immune Pharmaceuticals
Aug 14, 2013
―
Uninformative Buy
―
$7.05K
Oragenics
Dec 09, 2024
Director
Informative Sell
23.76
$22.01K
Medicinova
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Alan Dunton's performance on stock
You May Also Like
Alan Dunton insider profile FAQ
What is the percentage of profitable transactions made by Alan Dunton?
The percentage of profitable transactions made by Alan Dunton is 82%.
What is the average return per transaction made by Alan Dunton?
The average return per transaction made by Alan Dunton is 66.40%.
What stocks does Alan Dunton hold?
Alan Dunton holds: PTN, CRMD, GYRE, IMNPQ, OGEN, MNOV stocks.
What was Alan Dunton’s latest transaction?
Alan Dunton latest transaction was an Uninformative Buy of ―.
What was Alan Dunton's most profitable transaction?
Alan Dunton’s most profitable transaction was an Informative Buy of PTN stock on June 17, 2025. The return on the trade was 202.00%.
What is Alan Dunton's role in Palatin Technologies?
Alan Dunton's role in Palatin Technologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.